Dendreon Sells Royalty Interest

By Angela Sormani — 4 years ago

Dendreon Corporation has agreed to sell for $125 million in cash its royalty interest related to intellectual property licensed to Schering and associated with VICTRELIS, a treatment for chronic hepatitis C. The royalty interest was acquired by CPPIB Credit Investments, a wholly-owned subsidiary of CPP Investment Board. PRESS RELEASE Dendreon Corporation today announced that it […]